PRQR
ProQR Therapeutics N.V.
Company Overview
| Mkt Cap | $299.86M | Price | $2.75 |
| Volume | 803.75K | Change | +1.10% |
| P/E Ratio | -10.8 | Open | $2.72 |
| Revenue | $18.9M | Prev Close | $2.72 |
| Net Income | $-27.8M | 52W Range | $1.07 - $4.21 |
| Div Yield | N/A | Target | $8.88 |
| Overall | 61 | Value | -- |
| Quality | 31 | Technical | 91 |
No chart data available
Stock Overview
Updated DailyProQR Therapeutics N.V. (PRQR) is a leading Healthcare company in the Biotechnology industry, currently trading at $2.75 with a market capitalization of $299.86 million. The stock is trading in the middle of its 52-week range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 31.
Today's trading session shows PRQR with a volume of 804K shares. The stock opened down 0.00% from yesterday's close of $2.72. Current analyst estimates project earnings of $-0.4 per share for this year, with next year targeting $-0.48.
PRQR demonstrates very strong technical momentum based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including ATRA, ATNM, TLOG, AGEN.
Key investment considerations for PRQR include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 222.9%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 02:40 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRQR | $2.75 | +1.1% | 803.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |